Current opinion in oncology
The most recent articles from:
Curr Opin Oncol
-
Editorial Review
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Prevention of infectious complications of chemotherapy-induced granulocytopenia is a major issue in preventive medicine, as febrile neutropenia is still associated with an overall 10% mortality and extensive morbidity and cost. ⋯ It is likely that the consideration of these newly recognized risk factors and the availability of more affordable granulocyte colony-stimulating factors will lead, in the near future, to an extension of the presently recognized indications for the prescription of granulocyte colony-stimulating factors.